Adverse Events and Oncotargeted Kinase Inhibitors
Language: English
Published by Academic Pr, 2017
- Softcover
- New

Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
AbeBooks seller since January 6, 2003
Condition: New
US$ 332.95
Quantity: 1 available
Add to basketItem description from seller
715 pages. 10.50x8.25x2.00 inches. In Stock.
Seller Inventory # zk0128094001
- Title
- Adverse Events and Oncotargeted Kinase Inhibitors
- Author
- Tridente, Giuseppe
- Publisher
- Academic Pr
- Publication year
- 2017
- Condition
- Brand New
- Binding
- Paperback
- Language
- English
- ISBN 10
- 0128094001
- ISBN 13
- 9780128094006
- Item weight
- 2.24 kilograms
Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases.
A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement.
This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events.
- Offers a unique and comprehensive publication on the adverse events associated with a new and fast-growing class of medicines
- Provides a systematic analysis of adverse events aimed at better prevention through understanding and offering insights for the development of safer drugs
- Uses practical guidelines to establish a leading reference on this class of drugs for educators, researchers, drug developers, clinicians, safety professionals, and more
"Synopsis" may belong to another edition of this title.
About the Author
School of Medicine and Surgery
Coordinator of the Teachers’ Committee for the Master in Translational Biomedicine
Universita degli Studi di Verona, Italy
"About the title" may belong to another edition of this title.
Revaluation Books
Exeter, United Kingdom
AbeBooks seller since January 6, 2003
Shipping rates from United Kingdom to U.S.A.
| Item | 2 to 3 business days | 7 to 14 business days |
|---|---|---|
| First item | US$ 46.22 | US$ 46.22 |
Payment methods
Seller's business information
Edward Bowditch Ltd
Exstowe, Exton
Exeter, United Kingdom EX3 0PP
Terms of sale
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
Shipping terms
Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.